Strategic Equity Agreement, Astellas Pharma and Cytori Therapeutics (CYTX)
December 7th, 2010
No comments
CYTX and Astellas Pharma Inc. have entered into a strategic equity agreement to evaluate the potential of adipose derived stem and regenerative cells Read more…
Categories: NASDAQ: CYTX, Stem Cell Technology, strategic equity agreement
